Data / Form D filings / Vantix Diagnostics, Inc.
Vantix Diagnostics, Inc.: Form D filings
Vantix Diagnostics, Inc., a biotechnology company in Pelham, NH, filed 5 Form D notices with the SEC between 2012 and 2014. The latest, on February 11, 2014, reports $4.9 million sold of a $16 million offering to 52 investors.
Find out what Vantix Diagnostics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 70 BRIDGE ST. #8, Pelham, NH, 03076
- Phone
- (603) 459-0715
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1558003
The full lists. Form D filings in New Hampshire: 127 rows, $6.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 11, 2014 | Amendment | $16,000,000 | $4,947,000 | $11,053,000 | 52 | Jun 13, 2013 | sec.gov |
| Jan 23, 2013 | New notice | $16,000,000 | $0 | $16,000,000 | 0 | Yet to occur | sec.gov |
| Jan 23, 2013 | New notice | $250,000 | $0 | $250,000 | 0 | Yet to occur | sec.gov |
| Oct 19, 2012 | Amendment | $1,400,000 | $1,140,000 | $260,000 | 13 | Aug 30, 2012 | sec.gov |
| Sep 12, 2012 | New notice | $1,100,000 | $250,000 | $850,000 | 5 | Aug 30, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steve Lufkin | Executive Officer, Director, Promoter | |
| Doug Armstrong | Director | |
| Richard Wardle | Director | |
| Anthony Pintsopoulos | Promoter | |
| Richard Rappaport | Promoter |
Every Form D from the week of Feb 10, 2014 · All recent filings in New Hampshire · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vantix Diagnostics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.